MYDA Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-63,970
| Closed | -$301K | – | 123 |
|
|
2024
Q4 | $301K | Buy |
+63,970
| New | +$301K | 0.08% | 104 |
|
|
2024
Q1 | – | Sell |
-29,370
| Closed | -$198K | – | 117 |
|
|
2023
Q4 | $198K | Sell |
29,370
-20,630
| -41% | -$139K | 0.07% | 62 |
|
|
2023
Q3 | $222K | Hold |
50,000
| – | – | 0.07% | 79 |
|
|
2023
Q2 | $165K | Buy |
+50,000
| New | +$165K | 0.05% | 85 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 221 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 263 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$262K | – | 263 |
|
|
2021
Q2 | $262K | Buy |
25,000
+9,263
| +59% | +$97.1K | 0.07% | 215 |
|
|
2021
Q1 | $185K | Buy |
+15,737
| New | +$185K | 0.05% | 226 |
|